They found that the NLRP3 inflammasome inhibitor MCC950 significantly reduced cerebral infarct volume, inhibited caspase-1 activation, attenuated inflammation, and stabilized the blood-brain barrier, thereby preventing I/R injury. This evidence concerns the gene NLRP3 and infarction.